Comprehensive human brain drug discovery model selected by independent panel of experts
Boston, MA – December 1, 2021 – Emulate, Inc., a leading provider of next-generation in vitro models, today announced that its human Brain-Chip was ranked #4 on The Scientist magazine’s 2021 Top 10 Innovations list. The human Brain-Chip was first launched in December 2020 and is designed for researchers and drug developers who are investigating neuroinflammation and seeking to improve drug discovery for neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
The Scientist’s annual award recognizes important biomedical technologies that have the potential to generate a positive impact on scientific research. The human Brain-Chip was selected by The Scientist’s independent panel of expert judges for its potential impact on neurodegenerative disease research and drug discovery. Emulate Organ-Chips, including the human Brain-Chip, are designed to enable researchers to investigate the safety and efficacy of therapeutic treatments in vitro to mitigate the need for animal testing, as well as reduce the high cost and failure rates involved in preclinical drug development.
“The human Brain-Chip’s recognition on The Scientist‘s 2021 Top 10 Innovations list reflects a pivotal year that brought greater awareness of the pressing need for more effective drug discovery models,” said Emulate CTO and co-founder Daniel Levner. “It is encouraging to see multiple biological model providers showcased for pioneering work to bring new technologies that are more human-relevant to the drug discovery and development process.”
The human Brain-Chip’s recognition on The Scientist‘s 2021 Top 10 Innovations list reflects a pivotal year that brought greater awareness of the pressing need for more effective drug discovery models
Daniel Levner, Co-Founder & CTO, Emulate
The Scientist says this year’s list had an emphasis on innovations that persevered through the ongoing COVID-19 pandemic. “In a way, it’s heartening that scientific advances have continued to occur in spaces outside of the crucial coronavirus focus,” said Editor-in-Chief Bob Grant. “It suggests that the global biomedical apparatus is robust enough to address a pressing and pointed concern while not losing ground in fields not directly related to that crisis.”
About Emulate, Inc.
Emulate is igniting a new era in human health with industry-leading Organ-on-a-Chip technology. The Human Emulation System provides a window into the inner workings of human biology and disease — offering researchers an innovative technology designed to predict human response with greater precision and detail than conventional cell culture or animal-based experimental testing. Pioneered at the Wyss Institute for Biologically Inspired Engineering at Harvard University and backed by Northpond Ventures, Founders Fund, and Perceptive Advisors, Organ-on-a-Chip technology is assisting researchers across academia, pharma, and government industries through its predictive power and ability to recreate true-to-life human biology. To learn more, visit emulatebio.com or follow us on LinkedIn and Twitter.
Media Contact:
Emulate, Inc.
Michael Sullivan
+1 503-799-7520
